Skip to main content
. 2017 Mar 27;3(1):39–47. doi: 10.1016/j.bioactmat.2017.03.001

Fig. 5.

Fig. 5

A) Particle size distribution of PBPLP nanogels. B) Drug release profiles of PBPLP/DOX nanogels in 0.1 M acetic acid (pH 5.2) and 0.1 M phosphate buffer (pH 7.4). C) Pharmacological activity of PBPLP/DOX against prostate cancer cell lines (PC3). Figure legend: Media = pure media (negative control); PBPLP = 50 μg/ml nanogel (DOX-free control); PBPLP(DOX1, 2, or 3) = 5, 25, or 50 μg/ml respectively of nanogel loaded with 20 wt% of DOX; DOX = 10 μg/ml DOX (positive control). D) Light microscopy of PC3 cells incubated with PBPLP/DOX3 at 12 h (top left), 24 h (right), and 48 h (bottom left).